WASHINGTON, Nov. 21, 2019 /PRNewswire/ — MCRA, LLC (www.mcra.com) is pleased to announce that its client THINK Surgical, Inc. has obtained clearance from the U.S. Food and Drug Administration (FDA) to market the TSolution OneĀ® Total Knee Application for use in total knee arthroplasty (TKA) in the United States. THINK Surgical engaged MCRA to provide clinical study management …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone